Sembiosys Genetics Inc. SBIYF

Consistent Volume=New Life

[AaronW]

10/14/2011	0.080	0.090	0.080	0.090	215,000	0.005	5.88%
10/13/2011	0.090	0.090	0.085	0.085	144,000	0.000	0.00%
10/12/2011	0.100	0.100	0.085	0.085	365,250	-0.020	-19.05%
10/11/2011	0.070	0.180	0.070	0.105	1,482,200	0.050	90.91%
10/06/2011	0.080	0.080	0.055	0.055	19,900	0.005	10.00%
10/05/2011	0.080	0.080	0.050	0.050	17,200	-0.020	-28.57%
10/03/2011	0.070	0.070	0.070	0.070	20,000	0.000	0.00%
09/30/2011	0.070	0.070	0.070	0.070	20,500	-0.010	-12.50%
09/29/2011	0.085	0.085	0.080	0.080	13,500	-0.010	-11.11%
09/27/2011	0.090	0.090	0.080	0.090	40,525	0.000	0.00%
09/26/2011	0.085	0.090	0.085	0.090	7,900	0.005	5.88%

I believe this is a very good entry point and positives outweight the negatives in this JV

[Wormguy]

I agree,but I don't think we'll see a giant uptick until one of their products is approved in China.Don't forget that China is a huge market and this company isn't only the insulin product. They also make the Apo AI and Apo AImilano for cardiovascular disease. They also have a line of plants that are high in GLA, industrial enzymes like chymosin (also called rennin) and a

[Biotech777]

Not quite sure what to make of this one just yet. Despite all the hype, China is NOT a huge market yet. In fact it is a quite small market in the world of pharma right now. Having said that, it has very strong growth rates, which if continue, will make it a solid #3 or 4 market in the world in 10 years. The net profit interest is really hard to put a value around. If this is a typical research JV,

[AaronW]

10/17/2011 0.095 0.100 0.090 0.095 207,500 0.000 0.00% 10/14/2011 0.080 0.095 0.080 0.095 308,000 0.010 11.76% 10/13/2011 0.090 0.090 0.085 0.085